Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
XBIO

Xenetic

$2.60

-0.04 (-1.52%)

08:10
08/23/17
08/23
08:10
08/23/17
08:10
Hot Stocks
Xenetic announces dismissal of annual meeting of stockholders »

Xenetic Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

Over a month ago
XBIO

Xenetic

$2.82

-0.03 (-1.05%)

, SHPG

Shire

$147.77

-0.84 (-0.57%)

08:08
08/15/17
08/15
08:08
08/15/17
08:08
Hot Stocks
Xenetic provides update on PolyXen platform technology »

In May 2017, Xenetic…

XBIO

Xenetic

$2.82

-0.03 (-1.05%)

SHPG

Shire

$147.77

-0.84 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 08

    Sep

  • 11

    Sep

  • 26

    Sep

XBIO

Xenetic

$2.82

-0.03 (-1.05%)

08:07
08/15/17
08/15
08:07
08/15/17
08:07
Hot Stocks
Xenetic provides update on XBIO-101 program »

In the second quarter of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 26

    Sep

XBIO

Xenetic

$2.43

-0.02 (-0.82%)

08:42
06/26/17
06/26
08:42
06/26/17
08:42
Hot Stocks
Xenetic starts patient enrollment for Phase 2 study evaluating XBIO-101 »

Xenetic Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

Over a quarter ago
XBIO

Xenetic

$3.25

0.2599 (8.69%)

07:30
05/22/17
05/22
07:30
05/22/17
07:30
Hot Stocks
Breaking Hot Stocks news story on Xenetic »

Xenetic Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XBIO

Xenetic

$3.25

0.2599 (8.69%)

, SHPG

Shire

$189.14

-0.86 (-0.45%)

07:18
05/22/17
05/22
07:18
05/22/17
07:18
Hot Stocks
Xenetic says once-weekly dosing criterion not met in Shire SHP656 study »

Xenetic Biosciences…

XBIO

Xenetic

$3.25

0.2599 (8.69%)

SHPG

Shire

$189.14

-0.86 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 26

    Jun

XBIO

Xenetic

$3.25

0.2599 (8.69%)

, SHPG

Shire

$189.14

-0.86 (-0.45%)

07:07
05/22/17
05/22
07:07
05/22/17
07:07
Hot Stocks
Breaking Hot Stocks news story on Xenetic, Shire »

Xenetic says Shire…

XBIO

Xenetic

$3.25

0.2599 (8.69%)

SHPG

Shire

$189.14

-0.86 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 26

    Jun

XBIO

Xenetic

$3.25

0.2599 (8.69%)

07:00
05/22/17
05/22
07:00
05/22/17
07:00
Hot Stocks
Breaking Hot Stocks news story on Xenetic »

Xenetic Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XBIO

Xenetic

, SHPG

Shire

$181.91

-0.67 (-0.37%)

07:13
05/16/17
05/16
07:13
05/16/17
07:13
Hot Stocks
Xenetic provides update on license deal with Shire »

Xenetic (XBIO) provided…

XBIO

Xenetic

SHPG

Shire

$181.91

-0.67 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 06

    Jun

  • 26

    Jun

XBIO

Xenetic

07:12
05/16/17
05/16
07:12
05/16/17
07:12
Hot Stocks
Xenetic on track to commence patient recruitment in Q2 for XBIO-101 study »

Xenetic provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.